# EDGAR Filing Document

**Accession Number:** 0002089970
**File Stem:** 0000912282-25-001062
**Filing Date:** 2025-10
**Character Count:** 5719
**Document Hash:** d9a793757f2223846e9abede206aa362
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000912282-25-001062.hdr.sgml**: 20251010

**ACCESSION NUMBER**: 0000912282-25-001062

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20251010

**DATE AS OF CHANGE**: 20251010

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Flora Growth Corp.
- **CENTRAL INDEX KEY:** 0001790169
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A6
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-93855
- **FILM NUMBER:** 251387239

**BUSINESS ADDRESS:**
- **STREET 1:** 3230 W. COMMERCIAL BOULEVARD
- **STREET 2:** SUITE 180
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33309
- **BUSINESS PHONE:** 416-861-2267

**MAIL ADDRESS:**
- **STREET 1:** 3230 W. COMMERCIAL BOULEVARD
- **STREET 2:** SUITE 180
- **CITY:** FORT LAUDERDALE
- **STATE:** FL
- **ZIP:** 33309
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Reis-Faria Daniel
- **CENTRAL INDEX KEY:** 0002089970

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 40 KING ST W SUITE 2400
- **CITY:** TORONTO
- **PROVINCE COUNTRY:** A6
- **ZIP:** M5H 3Y2

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Flora Growth Corp.**

*(Name of Issuer)*

**Common Shares, no par value**

*(Title of Class of Securities)*

**339764102**

*(CUSIP Number)*

**Daniel Reis-Faria**<br>40 King Street W., Suite 2400<br>Toronto A6 M5H 3Y2<br>(954) 842-4989

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**10/09/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **339764102** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Reis-Faria Daniel** | Name of reporting person<br>**Reis-Faria Daniel** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**5954743.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**5954743.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**5954743.00** | Aggregate amount beneficially owned by each reporting person<br>**5954743.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**89.3%** | Percent of class represented by amount in Row (11)<br>**89.3%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Shares, no par value

**(b) Name of Issuer:**
Flora Growth Corp.

**(c) Address of Issuer's Principal Executive Offices:**
3230 W. Commercial Blvd., Suite 180, Fort Lauderdale, FL, 33132

**Item 4. Purpose of Transaction**

On September 20, 2025, the Reporting Person was appointed as a director and as Chief Executive Officer of the Issuer.  On October 9, 2025, the Reporting Person purchased 5,954,743 Token Pre-Funded Warrants (the "Warrants") from the Issuer at a purchase price of $25.1899 per Warrant, having an approximate total value of $149,999,977.  Subject to shareholder approval, the Warrants are exercisable for Common Shares, no par value, of the Issuer, at an exercise price of $0.0001 per Warrant.

**Item 5. Interest in Securities of the Issuer**

**(a)**
89.3%

**(b)**
5,954,743

**(c)**
Issuer private placement purchase of Token Pre-Funded Warrants on October 9, 2025.  The percentage holdings in Item 5(a) are based on a total of 712,355 outstanding common shares of the Issuer on October 9, 2025.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Securities Purchase Agreement dated as of October 9, 2025, by and between the Company and the Reporting Person and the other Token Pre-Funded Warrant investors identified therein
Employment Agreement dated September 20, 2025, by and between Flora Growth Corp. and Daniel Reis-Faria

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Reis-Faria Daniel

**Signature:** Daniel Reis-Faria

**Name/Title:** Reis-Faria Daniel

**Date:** 10/10/2025